All News about Silence Therapeutics Plc ADR
![](https://mms.businesswire.com/media/20230328005336/en/1748666/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230328005330/en/1748657/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics to Buyback siRNA Complement Assets
March 28, 2023
Via Business Wire
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/29/aapharma_9.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_170.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230315005297/en/1738892/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230301005424/en/1726689/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230208005074/en/1707275/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230206005194/en/1705352/22/JP_Gabriel_headshot.jpg)
![](https://mms.businesswire.com/media/20230112005311/en/1684288/5/Silence-Logo-FINAL-rgb.jpg)
From Silence Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20230103005195/en/1674928/5/Silence-Logo-FINAL-rgb.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/25/image14.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221110005384/en/1632403/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics Reports Third Quarter 2022 Results
November 10, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221109005129/en/1629829/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20221105005027/en/1625773/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20220929005148/en/1586374/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20220927005131/en/1582575/5/Silence-Logo-FINAL-rgb.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/08/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/08/bz-pharma_0.jpg?width=1200&height=800&fit=crop)
Silence Therapeutics Gets FDA Fast Track Status For Blood Cancer Candidate
September 08, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20220908005331/en/1565088/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics to Participate in September Investment Conferences
September 08, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220908005326/en/1565077/5/Silence-Logo-FINAL-rgb.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/26/image-electronic_arts.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220811005805/en/1542671/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics Announces Pricing of Underwritten Offering
August 11, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/08/19/image_2.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220602005054/en/1471857/5/Silence-Logo-FINAL-rgb.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/18/image46.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220518005052/en/1457745/5/Silence-Logo-FINAL-rgb.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/06/23/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220516005300/en/1455964/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.